Fig. 2From: Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trialEffect of empagliflozin vs. sitagliptin on HbA1CBack to article page